U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07466407) titled 'Effects of HMB and Rehabilitation Program in Athletes With Patellar Tendinopathy' on Feb. 26.
Brief Summary: This randomized, double-blind, placebo-controlled clinical trial evaluates the effects of oral beta-hydroxy-beta-methylbutyrate (HMB) supplementation combined with an eccentric exercise and extracorporeal shockwave rehabilitation program on pain, tendon morphology, and neuromuscular performance in athletes with patellar tendinopathy.
Thirty athletes with a confirmed diagnosis of patellar tendinopathy are randomized to receive either HMB supplementation (3 g/day) or placebo during an 8-week rehabilitation program. Participan...